Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Cyclosporine for Bronchiolitis Obliterans Syndrome
NCT01287078Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jan 2011
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cyclosporine Inhalation Solution in Bronchiolitis Obliterans Syndrome (BOS), sponsored by National Heart, Lung, and Blood Institute. Started Jan 2011; status: completed.
02
Drugs
Cyclosporine Inhalation Solution
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT01287078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01287078.